40-GEP Test Utilization Can Mitigate Financial Burden of Cutaneous Squamous Cell Carcinoma

Medicare-eligible patients with cutaneous squamous cell carcinoma (cSCC) could save on health care costs by utilizing the 40-gene expression profile (40-GEP) to guide treatment decisions.

Related Keywords

,Expression Analysis Concept ,Skin Cancer ,Cutaneous Squamous Cell Carcinoma ,Medicare ,Adjuvant Radiation Therapy ,Health Care Costs ,Gene Expression ,40 Gep ,